SecBot SecBot
SECBOTREPLAY Home › Report › RVMD

RVMD · Director and Officer Mark A

Revolution Medicines, Inc. · 144 filed Jun 15, 2026 at 18:30 ET

At the news

NEUTRALIMPACT 2/10

144 filed Jun 15, 2026 at 18:30 ET

Director and Officer Mark A. Goldsmith filed a Form 144 indicating intent to sell 9,772 shares of Revolution Medicines common stock, valued at approximately $1.5M based on the filing date price. The shares were acquired via restricted stock unit grants in 2023-2025. This is a routine sale consistent with Goldsmith's prior selling pattern (132,871 shares sold in the past three months) and does not signal a change in company outlook.

  • Mark A. Goldsmith (Officer/Director) filed Form 144 to sell 9,772 shares of RVMD common stock.
  • Estimated value of proposed sale: ~$1,503,617.64 (based on ~$153.86/share).
  • Shares to be sold were acquired from RSU grants on 03/01/2023 (3,488 shares), 03/01/2024 (3,018 shares), and 03/01/2025 (3,266 shares).
  • Goldsmith sold 12,871 shares on 03/17/2026 and 120,000 shares on 04/15/2026, totaling 132,871 shares in the prior three months.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access